Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

AMRI Global

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. The company provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

AMRI Global
Mostyn Road, Holywell, Flintshire, Wales, CH8 9DN, United Kingdom
+44 (0)1352 717100
Contact AMRI Global
Website

 Latest Content from PMHub 

Artificial Intelligence: the new healthcare algorithm

White Papers and Resources | September 27, 2016 | Blue Latitude Health

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare....

Lucid Group becomes a sponsor of MedComms Networking

Press Releases | September 23, 2016 | Lucid Group Communications Limited

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

Showcasing our multichannel capabilities in Berlin

White Papers and Resources | September 22, 2016 | Anthill Agency

Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications

DAM and CMS: managing assets to maximise adoption and value

White Papers and Resources | September 19, 2016 | Blue Latitude Health

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Tenth Lucid Academy module delivered – nurturing talent and driving excellence

Press Releases | September 15, 2016 | Lucid Group Communications Limited

Celebrating the success of the Lucid Academy

Lucid launch new recruitment campaign to attract top talent in medical writing

Press Releases | September 8, 2016 | Lucid Group Communications Limited

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Press Releases | September 7, 2016 | Lucid Group Communications Limited

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

White Papers and Resources | September 7, 2016 | Anthill Agency

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

White Papers and Resources | September 1, 2016 | Blue Latitude Health

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

A stumble, but not a fall – what’s next for Opdivo?

White Papers and Resources | August 25, 2016 | Blue Latitude Health

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.